Hirano Patricia C's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Aug 7, 2024
- Accession no.
- 0001415889-24-020944
- Filed
- Aug 7, 2024
- Trade date
- Aug 5-6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $502.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hirano Patricia CCIK 0001766042 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | Common Stock | SSaleDisposed | −2,834 | $45.48 | −$128,890.32 | 130,920 | Direct | |
| Aug 5, 2024 | Common Stock | SSaleDisposed | −2,198 | $46.14 | −$101,415.72 | 128,722 | Direct | |
| Aug 6, 2024 | Common Stock | SSaleDisposed | −587 | $43.64 | −$25,616.68 | 128,135 | Direct | |
| Aug 6, 2024 | Common Stock | SSaleDisposed | −1,983 | $45.25 | −$89,730.75 | 126,152 | Direct | |
| Aug 6, 2024 | Common Stock | SSaleDisposed | −3,407 | $45.89 | −$156,347.23 | 122,745 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.